ERBB2 and cancer: As well as interactions with HER2 and other EGFR receptor family members, a number of other factors influence EGFR signalling in cancer cells, such as receptor mutations and increased expression of ligands (Arteaga, 2002; Ciardiello and Tortora, 2003).